Granules India
GRANULESNSE

Granules India

₹699.70-4.85 (0.69%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
690.00
Today’s high
722.50
52 week low
430.70
52 week high
730.80
Open price
705.00
Previous close
704.55
Live volume
16,47,979
Lower circuit
559.80
Upper circuit
839.60

Fundamentals

Market Cap
₹17,327Cr
ROE
11.70%
P/E Ratio(TTM)
29.12
EPS(TTM)
24.01
P/B Ratio
3.41
Dividend Yield
0.25%
Industry P/E
33.38
Book Value
205.21
Debt to Equity
0.30
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹1,479
+6.87%
Profit (Cr)
₹202
+34.19%
04008001.2k1.6k
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+23%
3Y CAGR+6%
Profit growthValue
1Y (TTM)+33%
3Y CAGR+7.0%

About

With a four-decade legacy, Granules India evolved from an API maker into a vertically integrated, global pharmaceutical company with a world-class manufacturing platform. Its vision is to become a world leader in the green chemical and pharmaceutical industry by using cutting-edge technologies to enhance the quality of life. The company is propelled by its purpose of 'Healing Lives Responsibly through Pioneering Green Science,' delivering safe, effective, and affordable medicines across geographies. It operates across the value chain, delivering high-quality Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs) to worldwide healthcare markets. Granules is strategically expanding into high-growth areas like oncology and peptides to build a differentiated portfolio that underpins sustained global competitiveness. This global strategy supports its supply of 100+ molecules to over 300 customers in 80+ countries, backed by a manufacturing capacity of 10 billion dosages.;
CEO/MD
Dr. K.V.S. Ram Rao
Founded in
1991
NSE symbol
GRANULES

Shareholding Pattern

Jun '25
Sep '25
Dec '25
Feb '26
Mar '26
Promoters
38.02%
Retail And Others
29.66%
Foreign Institutions
15.31%
Other Domestic Institutions
14.16%
Mutual Funds
2.85%

Mutual Funds Invested (2)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Natco PharmaNATCOPHARM
₹1,095.75
+2.15 (0.20%)
L
    H
    19,627.7612.622.27
    ₹1,322.90
    +6.70 (0.51%)
    L
      H
      18,325.7638.935.21
      ₹926.60
      -0.25 (0.03%)
      L
        H
        14,763.1334.382.24
        ₹1,038.15
        +32.65 (3.25%)
        L
          H
          12,733.9023.424.22
          Livesquawk
          Granules plans 1-2 new controlled substance products annually for 2-3 years. Nine applications from its Gagillapur site await U.S. approval for launches.
          Livesquawk
          Granules India expects FY27 net debt to remain flat or slightly rise due to higher spending and working capital costs. Remediation costs for Gagillapur facility forecasted to drop sharply in FY27 after declines in late FY26.
          Livesquawk
          Granules India targets positive annual performance for peptide CDMO by FY27. Quarterly results may fluctuate as production schedules and ramp-ups normalize.
          Livesquawk
          Granules' North America revenue share dropped to 72% in Q4 FY26 from 79% in Q4 FY25. The decline reflects a shift in revenue mix away from North America.
          2026
          29
          Apr
          Quarterly & Annual Result
          Release date
          23
          Jan
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          12
          Aug
          Quarterly Result
          Release date

          31
          Jul
          Dividend
          Ex date
          ₹1.50
          per share

          For each share you hold, you will receive ₹1.50
          Dividend amount₹1.50 per share
          Dividend TypeFinal
          Ex Date31 Jul ‘25
          Record Date31 Jul ‘25
          Announcement date28 May ‘25

          28
          May
          Dividend
          Announced
          ₹1.50
          per share

          For each share you hold, you will receive ₹1.50
          Dividend amount₹1.50 per share
          Dividend TypeFinal
          Ex Date31 Jul ‘25
          Record Date31 Jul ‘25
          Announcement date28 May ‘25
          2024

          30
          Jul
          Dividend
          Ex date
          ₹1.50
          per share

          For each share you hold, you will receive ₹1.50
          Dividend amount₹1.50 per share
          Dividend TypeFinal
          Ex Date30 Jul ‘24
          Record Date30 Jul ‘24
          Announcement date15 May ‘24

          15
          May
          Dividend
          Announced
          ₹1.50
          per share

          For each share you hold, you will receive ₹1.50
          Dividend amount₹1.50 per share
          Dividend TypeFinal
          Ex Date30 Jul ‘24
          Record Date30 Jul ‘24
          Announcement date15 May ‘24
          Events calendar
          View upcoming events in other stocks